Alnylam Pharmaceuticals | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
Agios Pharmaceuticals USD 1.87B 654M 2024-12
Alnylam Pharmaceuticals USD 30.35B 4.96B 2024-12
Amgen USD 140.1B 33.03B 2024-12
Arrowhead Research USD 2.34B 69M 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Incyte USD 13.31B 576M 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis USD 230.87B 3.48B 2024-09
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Sanofi USD 145.36B 23.34B 2024-09
Takeda JPY 6.61T 16.72B 2024-12
Tectonic Therapeutic USD 447M 204M 2024-09
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12
Xencor USD 1.61B 203M 2024-12



Alnylam Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.